𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to tilting in hypertensive patients receiving ketanserin

✍ Scribed by L. A. Ferrara; F. Pasanisi; M. L. Fasano; S. Soro


Publisher
Springer
Year
1986
Tongue
English
Weight
131 KB
Volume
31
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparison of the hemodynamic responses
✍ Susan A. Cummings; Alberto J. Kaumann; Roberto J. Groszmann πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 529 KB

Ketanserin, a serotonin antagonist, is effective in lowering portal pressure in a rat model of portal hypertension. As ketanserin has al-adrenoceptor-blocking properties in addition to its serotonin-blocking effects, we sought to define further the mechanism of ketanserin's portal pressure-lowering

Long-term hemodynamic effects of ketanse
✍ Julio Vorobioff; Guadalupe Garcia-Tsao; Roberto Groszmann; Guillermo Aceves; Edu πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 511 KB

Ketanserin, a 5-hydroxytryptamine-2 receptor blocker, has been shown to decrease portal pressure in recent acute hemodynamic studies that have been performed both in experimental animals and portal hypertensive patients. The present study was designed to investigate the effects of chronic oral admin

Variable response to oral angiotensin-co
✍ Hendricks H. Whitman III; David B. Case; John H. Laragh; Charles L. Christian; G πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 672 KB

## Abstract Twelve scleroderma patients with hypertension, seven of whom had malignant hypertension and renal failure or scleroderma renal crisis, were treated with captopril. The first dose lowered mean pressure in all patients by 21.3 mmHg; in 6 patients it relieved encephalopathy. Blood pressure

Relationship between immune response to
✍ Frederic C. Mcduffie πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 250 KB

## Abstract In a prospective study of 21 hypertensive patients receiving hydralazine for 1 year, we found a close relationship between development of antibodies to deoxyribonucleoprotein (DNP) and to hydralazine but no evidence for cross‐reactivity between antibodies to these two antigens. Of 8 pat